Combined administration of alpha-erythropoietin and filgrastim can improve the outcome and cost balance of autologous stem cell transplantation in patients with lymphoproliferative disorders.

about

Autologous hematopoietic progenitor cell transplantation for multiple myeloma through an outpatient program.

P2860

Q38025703-99A8B33E-AC42-4400-B9C9-155D7FE10A3C

P2860

Combined administration of alpha-erythropoietin and filgrastim can improve the outcome and cost balance of autologous stem cell transplantation in patients with lymphoproliferative disorders.

Item

http://www.wikidata.org/entity/Q40528386

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Combined administration of alp ...... lymphoproliferative disorders.

@en

type

Item

label

Combined administration of alp ...... lymphoproliferative disorders.

@en

prefLabel

Combined administration of alp ...... lymphoproliferative disorders.

@en

P1476

Combined administration of alp ...... lymphoproliferative disorders

@en

P2093

Capelli D

http://www.w3.org/2001/XMLSchema#string

Gini G

http://www.w3.org/2001/XMLSchema#string

Leoni P

http://www.w3.org/2001/XMLSchema#string

Lucesole M

http://www.w3.org/2001/XMLSchema#string

Masia MC

http://www.w3.org/2001/XMLSchema#string

Montanari M

http://www.w3.org/2001/XMLSchema#string

Olivieri A

http://www.w3.org/2001/XMLSchema#string

Poloni A

http://www.w3.org/2001/XMLSchema#string

Raggetti GM

http://www.w3.org/2001/XMLSchema#string

Scortechini I

http://www.w3.org/2001/XMLSchema#string

P2860

Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cellautotransplant: a retrospective study.

Ex vivo expansion of megakaryocyte progenitor cells from normal bone marrow and peripheral blood and from patients with haematological malignancies.

Erythropoietin in stem cell transplantation.

Low-dose filgrastim significantly enhances neutrophil recovery following autologous peripheral-blood stem-cell transplantation in patients with lymphoproliferative disorders: evidence for clinical and economic benefit.

Randomized study of growth factors post-peripheral-blood stem-cell transplant: neutrophil recovery is improved with modest clinical benefit.

Health, economic, and quality-of-life effects of erythropoietin and granulocyte colony-stimulating factor for the treatment of myelodysplastic syndromes: a randomized, controlled trial.

Costs of care associated with high-dose therapy and autologous transplantation for non-Hodgkin's lymphoma: results from the University of Nebraska Medical Center 1989 to 1995.

P2888

sj.bmt.1704643

P304

693-702

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BMT.1704643

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Massimo Offidani

P577

2004-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8411382

http://www.w3.org/2001/XMLSchema#string

P6179

1039501465

http://www.w3.org/2001/XMLSchema#string

P698

15300235

http://www.w3.org/2001/XMLSchema#string

P921

Erythropoietin

Combined administration of alpha-erythropoietin and filgrastim can improve the outcome and cost balance of autologous stem cell transplantation in patients with lymphoproliferative disorders.

about

P2860

P2860

Combined administration of alpha-erythropoietin and filgrastim can improve the outcome and cost balance of autologous stem cell transplantation in patients with lymphoproliferative disorders.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P6179

P698

P921